-
1
-
-
0024533068
-
Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases
-
Carter CL, Allen C and Henson DE: Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63: 181-187, 1989.
-
(1989)
Cancer
, vol.63
, pp. 181-187
-
-
Carter, C.L.1
Allen, C.2
Hensont, D.E.3
-
2
-
-
0025279110
-
How to use prognostic factors in axillary node-negative breast cancer patients
-
McGuire EG, Tandon AK, Allred DC et al: How to use prognostic factors in axillary node-negative breast cancer patients. J Natl Cancer Inst 82: 1006-1015, 1990.
-
(1990)
J Natl Cancer Inst
, vol.82
, pp. 1006-1015
-
-
McGuire, E.G.1
Tandon, A.K.2
Allred, D.C.3
-
3
-
-
0026072872
-
Pathological prognostic factors in breast cancer I. The value of histological grade in breast cancer: Experience from a larger study with long-term follow-up
-
Elston CW and Ellis IO: Pathological prognostic factors in breast cancer I. The value of histological grade in breast cancer: experience from a larger study with long-term follow-up. Histopathol 19: 403-410, 1991.
-
(1991)
Histopathol
, vol.19
, pp. 403-410
-
-
Elston, C.W.1
Ellis, I.O.2
-
4
-
-
0025916196
-
Prognosis and breast cancer. Recognition of lethal and favorable prognostic types
-
Page DL: Prognosis and breast cancer. Recognition of lethal and favorable prognostic types. Am J Surg Pathol 75: 334-349, 1991.
-
(1991)
Am J Surg Pathol
, vol.75
, pp. 334-349
-
-
Page, D.L.1
-
5
-
-
15644376845
-
The importance of histologic grade of invasive breast carcinoma and response to chemotherapy
-
Pinder SE, Murray S, Ellis IO et al: The importance of histologic grade of invasive breast carcinoma and response to chemotherapy. Cancer 83: 1529-1539, 1998.
-
(1998)
Cancer
, vol.83
, pp. 1529-1539
-
-
Pinder, S.E.1
Murray, S.2
Ellis, I.O.3
-
6
-
-
0021813919
-
Long term survivors after breast cancer
-
Dixon JM, Page DL, Anderson TJ et al: Long term survivors after breast cancer. Br J Surg 72: 445-448, 1985.
-
(1985)
Br J Surg
, vol.72
, pp. 445-448
-
-
Dixon, J.M.1
Page, D.L.2
Anderson, T.J.3
-
7
-
-
0026639108
-
Prognostic factors and treatment decisions in node-negative breast cancer
-
McGuire W and Clark C: Prognostic factors and treatment decisions in node-negative breast cancer. N Engl J Med 326: 1756-1761, 1992.
-
(1992)
N Engl J Med
, vol.326
, pp. 1756-1761
-
-
McGuire, W.1
Clark, C.2
-
8
-
-
0028991396
-
Mutation of cell cycle regulators
-
Cordon-Cardo C: Mutation of cell cycle regulators. Am J Pathol 147: 545-560, 1995.
-
(1995)
Am J Pathol
, vol.147
, pp. 545-560
-
-
Cordon-Cardo, C.1
-
9
-
-
0028988585
-
Inhibitors of mammalian G1 cyclin-dependent kinases
-
Sherr CJM and Roberts JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9: 1149-1163, 1995.
-
(1995)
Genes Dev
, vol.9
, pp. 1149-1163
-
-
Sherr, C.J.M.1
Roberts, J.M.2
-
10
-
-
0028179669
-
KiP1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest
-
KiP1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev 8: 9-22, 1994.
-
(1994)
Genes Dev
, vol.8
, pp. 9-22
-
-
Polyak, K.1
Kato, J.Y.2
Solomon, M.J.3
-
11
-
-
0028909645
-
Human cyclin E, a nuclear protein essential for Gl to S phase transition
-
Ohtsubo M, Theodoras AM, Schumacher J et al: Human cyclin E, a nuclear protein essential for Gl to S phase transition. Mol Cell Biol 75: 2612-2624, 1995.
-
(1995)
Mol Cell Biol
, vol.75
, pp. 2612-2624
-
-
Ohtsubo, M.1
Theodoras, A.M.2
Schumacher, J.3
-
12
-
-
0033564697
-
CDK inhibitors: Positive and negative regulators of G1-S phase progression
-
Sherr CJ and Roberts JM: CDK inhibitors: positive and negative regulators of G1-S phase progression. Genes Dev 13: 1501-1512, 1999.
-
(1999)
Genes Dev
, vol.13
, pp. 1501-1512
-
-
Sherr, C.J.1
Roberts, J.M.2
-
13
-
-
0034738420
-
WAF1/cip1: More than a break to the cell cycle?
-
WAF1/cip1: more than a break to the cell cycle? Bioch Bioph Acta 1471: M43-M56, 2000.
-
(2000)
Bioch Bioph Acta
, vol.1471
-
-
Dotto, G.P.1
-
14
-
-
0037304898
-
New roles for p21 and p27 cell-cycle inhibitors: A function for each cell compartment?
-
Coqueret O: New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol 13: 65-70, 2003.
-
(2003)
Trends Cell Biol
, vol.13
, pp. 65-70
-
-
Coqueret, O.1
-
15
-
-
0027496935
-
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of cyclin-dependent kinases
-
Harper JW, Adami GR, Wei N et al: The p21 Cdk-interacting protein Cip1 is a potent inhibitor of cyclin-dependent kinases. Cell 5: 805-816, 1993.
-
(1993)
Cell
, vol.5
, pp. 805-816
-
-
Harper, J.W.1
Adami, G.R.2
Wei, N.3
-
16
-
-
0027717617
-
P21 a universal inhibitor of cyclin kinases
-
Xiong Y, Hannon GJ, Zhang H et al: P21 a universal inhibitor of cyclin kinases. Nature 366: 701-704, 1993.
-
(1993)
Nature
, vol.366
, pp. 701-704
-
-
Xiong, Y.1
Hannon, G.J.2
Zhang, H.3
-
17
-
-
0027359827
-
WAF1, a potential mediator of p53 tumour suppression
-
El-Deiry WS, Tokino T, Velculescu VE et al: WAF1, a potential mediator of p53 tumour suppression. Cell 75: 817-825, 1993.
-
(1993)
Cell
, vol.75
, pp. 817-825
-
-
El-Deiry, W.S.1
Tokino, T.2
Velculescu, V.E.3
-
18
-
-
0028236846
-
Induction of WAF1/CIP1 by a p53 independent pathway
-
Michielli P, Chedid M, Lin D et al: Induction of WAF1/CIP1 by a p53 independent pathway. Cancer Res 54: 3391-3395, 1994.
-
(1994)
Cancer Res
, vol.54
, pp. 3391-3395
-
-
Michielli, P.1
Chedid, M.2
Lin, D.3
-
19
-
-
0027109075
-
P53, guardian of the genome
-
Lane DP: P53, guardian of the genome. Nature 358: 15-16, 1992.
-
(1992)
Nature
, vol.358
, pp. 15-16
-
-
Lane, D.P.1
-
20
-
-
0027728976
-
How p53 suppresses cell growth
-
Marx J: How p53 suppresses cell growth. Science 262: 1644-1645, 1993.
-
(1993)
Science
, vol.262
, pp. 1644-1645
-
-
Marx, J.1
-
21
-
-
0030941458
-
P53, the cellular gatekeeper for growth and division
-
Levine AJ: P53, the cellular gatekeeper for growth and division. Cell 88: 323-331, 1997.
-
(1997)
Cell
, vol.88
, pp. 323-331
-
-
Levine, A.J.1
-
22
-
-
16944363001
-
Decreased levels of the cell cycle inhibitor p27(kip) protein: Prognostic implications in primary breast cancer
-
Catzavelos C, Bhattacharya N, Ung YC et al: Decreased levels of the cell cycle inhibitor p27(kip) protein: prognostic implications in primary breast cancer. Nature Med 3: 227-230, 1997.
-
(1997)
Nature Med
, vol.3
, pp. 227-230
-
-
Catzavelos, C.1
Bhattacharya, N.2
Ung, Y.C.3
-
23
-
-
0031048716
-
Expression of cell cycle regulators p27kip and cyclin E alone and in combination, correlate with survival in young breast cancer patients
-
Porter PL, Malone KE, Heagerty PJ et al: Expression of cell cycle regulators p27kip and cyclin E alone and in combination, correlate with survival in young breast cancer patients. Nature Med 3: 222-225, 1997.
-
(1997)
Nature Med
, vol.3
, pp. 222-225
-
-
Porter, P.L.1
Malone, K.E.2
Heagerty, P.J.3
-
24
-
-
0030894787
-
The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a, b) invasive breast carcinomas
-
Tan P, Cady B, Wanner M et al: The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a, b) invasive breast carcinomas. Cancer Res 57: 1259-1263, 1997.
-
(1997)
Cancer Res
, vol.57
, pp. 1259-1263
-
-
Tan, P.1
Cady, B.2
Wanner, M.3
-
25
-
-
0033012770
-
P27 expression as a prognostic factor of breast cancer in Taiwan
-
Chu JS, Huang CS and Chang KJ: P27 expression as a prognostic factor of breast cancer in Taiwan. Cancer Lett 141: 123-130, 1999.
-
(1999)
Cancer Lett
, vol.141
, pp. 123-130
-
-
Chu, J.S.1
Huang, C.S.2
Chang, K.J.3
-
26
-
-
0032796973
-
kiP1 protein is associated with poor clinical outcome of breast cancer patients treated with systemic chemotherapy and is linked to cell proliferation and differentiation
-
kiP1 protein is associated with poor clinical outcome of breast cancer patients treated with systemic chemotherapy and is linked to cell proliferation and differentiation. Breast Cancer Res Treat 55: 161-167, 1999.
-
(1999)
Breast Cancer Res Treat
, vol.55
, pp. 161-167
-
-
Han, S.1
Park, K.2
Kim, H.Y.3
-
27
-
-
0345369680
-
Prognostic impact of cyclin-dependent kinase inhibitor p27/kip1 in node-positive breast cancer
-
Tsuchiya A, Zhang, GJ and Kanno M: Prognostic impact of cyclin-dependent kinase inhibitor p27/kip1 in node-positive breast cancer. J Surg Oncol 70: 230-4, 1999.
-
(1999)
J Surg Oncol
, vol.70
, pp. 230-234
-
-
Tsuchiya, A.1
Zhang, G.J.2
Kanno, M.3
-
28
-
-
0032587341
-
KiP1 and apoptosis in human breast cancer
-
KiP1 and apoptosis in human breast cancer. Br J Cancer 79: 1572-1578, 1999.
-
(1999)
Br J Cancer
, vol.79
, pp. 1572-1578
-
-
Wu, J.1
Shen, Z.Z.2
Lu, J.-S.3
-
29
-
-
0035170004
-
Expression of cell cycle regulator p27 is correlated to the prognosis and ER expression in breast carcinoma patients
-
Nohara T, Ryo T, Iwamoto S et al: Expression of cell cycle regulator p27 is correlated to the prognosis and ER expression in breast carcinoma patients. Oncology 60: 94-100, 2001.
-
(2001)
Oncology
, vol.60
, pp. 94-100
-
-
Nohara, T.1
Ryo, T.2
Iwamoto, S.3
-
30
-
-
0032902972
-
Cyclin-dependent kinase inhibitor p27/kip1 expression and interaction with other cell cycle-associated proteins in mammary carcinoma
-
Gillett CE, Smith P, Peters G et al: Cyclin-dependent kinase inhibitor p27/kip1 expression and interaction with other cell cycle-associated proteins in mammary carcinoma. J Pathol 187: 200-206, 1999.
-
(1999)
J Pathol
, vol.187
, pp. 200-206
-
-
Gillett, C.E.1
Smith, P.2
Peters, G.3
-
31
-
-
0032780931
-
Elevated levels of p27, p21 and cyclin D1 correlate with positive oestrogen and progesterone receptor status in node negative breast carcinoma patients
-
Reed W, Florenes VA, Holm R et al: Elevated levels of p27, p21 and cyclin D1 correlate with positive oestrogen and progesterone receptor status in node negative breast carcinoma patients. Virchows Arch 435: 116-124, 1999.
-
(1999)
Virchows Arch
, vol.435
, pp. 116-124
-
-
Reed, W.1
Florenes, V.A.2
Holm, R.3
-
32
-
-
0033917031
-
P27(kip1) expression in breast carcinomas: An immunohistochemical study on 512 patients with long-term follow-up
-
Barbareschi M, van Tinteren H, Mauri FA et al: p27(kip1) expression in breast carcinomas: an immunohistochemical study on 512 patients with long-term follow-up. Int J Cancer 89: 236-241, 2000.
-
(2000)
Int J Cancer
, vol.89
, pp. 236-241
-
-
Barbareschi, M.1
Van Tinteren, H.2
Mauri, F.A.3
-
33
-
-
0034688189
-
Cell cycle proteins do not predict outcome in grade I infiltrating ductal carcinoma of the breast
-
Leong AC, Hanby AM, Potts HW et al: Cell cycle proteins do not predict outcome in grade I infiltrating ductal carcinoma of the breast. Int J Cancer 89: 26-31, 2000.
-
(2000)
Int J Cancer
, vol.89
, pp. 26-31
-
-
Leong, A.C.1
Hanby, A.M.2
Potts, H.W.3
-
34
-
-
0033731947
-
Prognostic significance of biologic markers in node-negative breast cancer patients: A prospective study
-
Volpi A, De Paola F, Nanni O et al: Prognostic significance of biologic markers in node-negative breast cancer patients: a prospective study. Breast Cancer Res Treat 63: 181-192, 2000.
-
(2000)
Breast Cancer Res Treat
, vol.63
, pp. 181-192
-
-
Volpi, A.1
De Paola, F.2
Nanni, O.3
-
35
-
-
0037377745
-
Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and benefit from one course of perioperative chemotherapy in patients with negative lymph node status
-
Spataro VJ, Litman H, Viale G et al: Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and benefit from one course of perioperative chemotherapy in patients with negative lymph node status. Cancer 97: 1591-1600, 2003.
-
(2003)
Cancer
, vol.97
, pp. 1591-1600
-
-
Spataro, V.J.1
Litman, H.2
Viale, G.3
-
36
-
-
0026724877
-
Accumulation of p53 tumor suppressor gene protein: An independent marker of prognosis in breast cancers
-
Thor AD, Moore DH II, Edgerton SM et al: Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J Natl Cancer Inst 84: 845-855, 1992.
-
(1992)
J Natl Cancer Inst
, vol.84
, pp. 845-855
-
-
Thor, A.D.1
Moore II, D.H.2
Edgerton, S.M.3
-
37
-
-
0027394794
-
Association of p53 protein expression with tumour cell proliferation rate and clinical outcome in node negative breast cancer
-
Allred DC, Clark GM, Elledge R et al: Association of p53 protein expression with tumour cell proliferation rate and clinical outcome in node negative breast cancer. J Natl Cancer Inst 85: 200-206, 1993.
-
(1993)
J Natl Cancer Inst
, vol.85
, pp. 200-206
-
-
Allred, D.C.1
Clark, G.M.2
Elledge, R.3
-
38
-
-
0027278584
-
Immunohistochemical detection of p53 protein in mammary carcinoma: An important new independent indicator of prognosis?
-
Barnes DM, Dublin EA, Fisher CJ et al: Immunohistochemical detection of p53 protein in mammary carcinoma: an important new independent indicator of prognosis? Hum Pathol 24: 469-476, 1993.
-
(1993)
Hum Pathol
, vol.24
, pp. 469-476
-
-
Barnes, D.M.1
Dublin, E.A.2
Fisher, C.J.3
-
39
-
-
0026659891
-
Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node negative breast cancer patients
-
Isola J, Viskorpi T, Holli Kaija et al: Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node negative breast cancer patients J Natl Cancer Inst 84: 1109-1114, 1992.
-
(1992)
J Natl Cancer Inst
, vol.84
, pp. 1109-1114
-
-
Isola, J.1
Viskorpi, T.2
Kaija, H.3
-
40
-
-
0028986873
-
P53 in node-negative breast carcinoma: An immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis
-
Rosen PP, Lesser ML, Arroyo CD et al: p53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis. J Clin Oncol 13: 821-830, 1995.
-
(1995)
J Clin Oncol
, vol.13
, pp. 821-830
-
-
Rosen, P.P.1
Lesser, M.L.2
Arroyo, C.D.3
-
41
-
-
0029883680
-
A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer
-
Michalides R, Hageman P, van Tinteren H et al: A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. Br J Cancer 73: 728-734, 1996.
-
(1996)
Br J Cancer
, vol.73
, pp. 728-734
-
-
Michalides, R.1
Hageman, P.2
Van Tinteren, H.3
-
42
-
-
0009941731
-
Prognostic factors in breast cancer
-
College of American Pathologists Consensus Statement 1999
-
Fitzgibbons PL, Page DL, Weaver D et al: Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124: 966-978, 2000.
-
(2000)
Arch Pathol Lab Med
, vol.124
, pp. 966-978
-
-
Fitzgibbons, P.L.1
Page, D.L.2
Weaver, D.3
-
43
-
-
0034651899
-
The prognostic value of p53 and c-erb B2 immunostaining is overrated for patients with lymph node negative breast carcinoma
-
Reed W, Hannisdal E, Boehler PJ et al: The prognostic value of p53 and c-erb B2 immunostaining is overrated for patients with lymph node negative breast carcinoma. Cancer 88: 804-813, 2000.
-
(2000)
Cancer
, vol.88
, pp. 804-813
-
-
Reed, W.1
Hannisdal, E.2
Boehler, P.J.3
-
44
-
-
0029665943
-
WAF1 immunohistochemical expression in breast carcinoma: Correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival
-
WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival. Br J Cancer 74: 208-215, 1996.
-
(1996)
Br J Cancer
, vol.74
, pp. 208-215
-
-
Barbareshi, M.1
Caffo, O.2
Doglioni, C.3
-
45
-
-
0030667191
-
P21/waf1/cip1 and mdm-2 expression in breast carcinoma patients is related to prognosis
-
Jiang M, Shao ZM, Wu J et al: P21/waf1/cip1 and mdm-2 expression in breast carcinoma patients is related to prognosis. Int J Cancer 74: 529-534, 1997.
-
(1997)
Int J Cancer
, vol.74
, pp. 529-534
-
-
Jiang, M.1
Shao, Z.M.2
Wu, J.3
-
46
-
-
0031004664
-
P21 (Waf/Cip 1) and p53 protein expression in breast cancer
-
Wakasugi E, Kobayashi T, Tamaki Y et al: p21 (Waf/Cip 1) and p53 protein expression in breast cancer. Am J Clin Pathol 107: 684-691, 1997.
-
(1997)
Am J Clin Pathol
, vol.107
, pp. 684-691
-
-
Wakasugi, E.1
Kobayashi, T.2
Tamaki, Y.3
-
47
-
-
2642641300
-
P21/WAF1/CIP1 is associated with cyclin D1/CCND1 expression and tubular differentiation but is independent of p53 overexpression in human breast carcinoma
-
Rey MJ, Fernandez PL, Jares P et al: p21/WAF1/CIP1 is associated with cyclin D1/CCND1 expression and tubular differentiation but is independent of p53 overexpression in human breast carcinoma J Pathol 184: 265-271, 1998.
-
(1998)
J Pathol
, vol.184
, pp. 265-271
-
-
Rey, M.J.1
Fernandez, P.L.2
Jares, P.3
-
49
-
-
0348134963
-
Expression of the cell cycle regulatory proteins p34/cdc2, p21/waf1, and p53 in node negative invasive ductal breast carcinoma
-
Kourea HP, Koutras AK, Scopa CD et al: Expression of the cell cycle regulatory proteins p34/cdc2, p21/waf1, and p53 in node negative invasive ductal breast carcinoma. J Clin Pathol Mol 56: 328-335, 2003.
-
(2003)
J Clin Pathol Mol
, vol.56
, pp. 328-335
-
-
Kourea, H.P.1
Koutras, A.K.2
Scopa, C.D.3
-
50
-
-
0033205230
-
P27 expression, a cyclin dependent kinase inhibitor in breast carcinoma
-
Barbareshi M: p27 expression, a cyclin dependent kinase inhibitor in breast carcinoma. Adv Clin Pathol 3: 119-127, 1999.
-
(1999)
Adv Clin Pathol
, vol.3
, pp. 119-127
-
-
Barbareshi, M.1
-
51
-
-
0036569518
-
High expression levels of p27 correlate with lymph node status in a subset of advanced invasive breast carcinomas. Relation to e-cadherin alterations, proliferative activity, and ploidy of the tumors
-
Kouvaraki M, Gorgoulis VG, Rassidakis GZ et al: High expression levels of p27 correlate with lymph node status in a subset of advanced invasive breast carcinomas. Relation to e-cadherin alterations, proliferative activity, and ploidy of the tumors. Cancer 94: 2454-2465, 2002.
-
(2002)
Cancer
, vol.94
, pp. 2454-2465
-
-
Kouvaraki, M.1
Gorgoulis, V.G.2
Rassidakis, G.Z.3
-
52
-
-
18644370396
-
Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer
-
Viglietto G, Motti ML, Bruni P et al: Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. Nat Med 8: 1136-1144, 2002.
-
(2002)
Nat Med
, vol.8
, pp. 1136-1144
-
-
Viglietto, G.1
Motti, M.L.2
Bruni, P.3
-
53
-
-
18644376449
-
PKB/Akt phosphorylates p27 and opposes p27-mediated G1-arrest
-
Liang J, Zubovitz J, Petrocelli T et al: PKB/Akt phosphorylates p27 and opposes p27-mediated G1-arrest. Nat Med 8: 1153-1160, 2002.
-
(2002)
Nat Med
, vol.8
, pp. 1153-1160
-
-
Liang, J.1
Zubovitz, J.2
Petrocelli, T.3
-
54
-
-
0032762177
-
Expression of p27/kip and other cell cycle regulators in malignant peripheral nerve sheath tumors and neurofibromas. The emerging role of p27 in malignant transformation of neurofibromas
-
Kourea HP, Cordon-Cardo C, Dudas M et al: Expression of p27/kip and other cell cycle regulators in malignant peripheral nerve sheath tumors and neurofibromas. The emerging role of p27 in malignant transformation of neurofibromas. Am J Pathol 755: 1885-1891, 1999.
-
(1999)
Am J Pathol
, vol.755
, pp. 1885-1891
-
-
Kourea, H.P.1
Cordon-Cardo, C.2
Dudas, M.3
-
55
-
-
0034092911
-
Regulation of the cdk inhibitor p27 and its deregulation in cancer
-
Slingerland J and Pagano M: Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol 183: 10-17, 2000.
-
(2000)
J Cell Physiol
, vol.183
, pp. 10-17
-
-
Slingerland, J.1
Pagano, M.2
-
56
-
-
0343627996
-
P27(kip1) expression in rectal cancer correlates with disease-free survival
-
Gunther K, Jung A, Volker U et al: p27(kip1) expression in rectal cancer correlates with disease-free survival. J Surg Res 92: 78-84, 2000.
-
(2000)
J Surg Res
, vol.92
, pp. 78-84
-
-
Gunther, K.1
Jung, A.2
Volker, U.3
-
57
-
-
0030223056
-
Prognostic value of p21/waf1 and p53 expression in breast carcinoma: An immunohistochemical study of 261 patients with long-term follow-up
-
Caffo O, Doglioni C, Veronese S et al: Prognostic value of p21/waf1 and p53 expression in breast carcinoma: an immunohistochemical study of 261 patients with long-term follow-up. Clin Cancer Res 2: 1591-1599, 1996.
-
(1996)
Clin Cancer Res
, vol.2
, pp. 1591-1599
-
-
Caffo, O.1
Doglioni, C.2
Veronese, S.3
-
59
-
-
0037338643
-
P21/WAF1 expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosis
-
Pellikainen MJ, Pekola TT, Ropponen KM et al: p21/WAF1 expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosis. J Clin Pathol 56: 214-220, 2003.
-
(2003)
J Clin Pathol
, vol.56
, pp. 214-220
-
-
Pellikainen, M.J.1
Pekola, T.T.2
Ropponen, K.M.3
-
60
-
-
0346485798
-
WAF1/ciP1 expression is correlated with her-2/neu in breast cancer and is an independent predictor of prognosis
-
WAF1/ciP1 expression is correlated with her-2/neu in breast cancer and is an independent predictor of prognosis. Breast Cancer Res 5: 242-249, 2003.
-
(2003)
Breast Cancer Res
, vol.5
, pp. 242-249
-
-
Winters, Z.E.1
Leek, R.D.2
Bradburn, M.J.3
-
61
-
-
0030973878
-
New functional activities for the p21 family of CDK inhibitors
-
LaBaer J, Garrett MD, Stevenson LF et al: New functional activities for the p21 family of CDK inhibitors. Genes Develop 11: 847-862, 1997.
-
(1997)
Genes Develop
, vol.11
, pp. 847-862
-
-
Labaer, J.1
Garrett, M.D.2
Stevenson, L.F.3
-
62
-
-
0027361822
-
Prognostic significance of p53 gene alterations in node negative breast cancer
-
Elledge RM, Fuqua SA, Clark GM et al: Prognostic significance of p53 gene alterations in node negative breast cancer. Breast Cancer Res Treat 26: 225-235, 1993.
-
(1993)
Breast Cancer Res Treat
, vol.26
, pp. 225-235
-
-
Elledge, R.M.1
Fuqua, S.A.2
Clark, G.M.3
-
63
-
-
0031777159
-
Analysis of p53 gene mutation by polymerase chain reaction-single strand conformation polymorphism provides independent prognostic information in node-negative breast cancer
-
Iacopetta B, Grieu F, Powell B et al: Analysis of p53 gene mutation by polymerase chain reaction-single strand conformation polymorphism provides independent prognostic information in node-negative breast cancer. Clin Cancer Res 4: 1597-1602, 1998.
-
(1998)
Clin Cancer Res
, vol.4
, pp. 1597-1602
-
-
Iacopetta, B.1
Grieu, F.2
Powell, B.3
-
64
-
-
0032814777
-
Somatic mutations in the p53 gene and prognosis in breast cancer: A meta-analysis
-
Pharoah PD, Day NE, Caldas C et al: Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis. Br J Cancer 80: 1968-1973, 1999.
-
(1999)
Br J Cancer
, vol.80
, pp. 1968-1973
-
-
Pharoah, P.D.1
Day, N.E.2
Caldas, C.3
-
65
-
-
0037374686
-
CIP1/WAF1 in antiproliferative effect of ZD1839 ("Iressa"), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells
-
CIP1/WAF1 in antiproliferative effect of ZD1839 ("Iressa"), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells. J Cell Physiol 795: 139-150, 2003.
-
(2003)
J Cell Physiol
, vol.795
, pp. 139-150
-
-
Di Gennaro, E.1
Barbarino, M.2
Bruzzese, F.3
|